TD Waterhouse Canada’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-933
| Closed | -$14.9K | – | 1950 |
|
|
2024
Q4 | $14.9K | Hold |
933
| – | – | ﹤0.01% | 1337 |
|
|
2024
Q3 | $35.6K | Hold |
933
| – | – | ﹤0.01% | 1121 |
|
|
2024
Q2 | $39.9K | Hold |
933
| – | – | ﹤0.01% | 1072 |
|
|
2024
Q1 | $39.9K | Hold |
933
| – | – | ﹤0.01% | 1101 |
|
|
2023
Q4 | $73.5K | Hold |
933
| – | – | ﹤0.01% | 872 |
|
|
2023
Q3 | $25.7K | Hold |
933
| – | – | ﹤0.01% | 1056 |
|
|
2023
Q2 | $49.4K | Hold |
933
| – | – | ﹤0.01% | 932 |
|
|
2023
Q1 | $63.4K | Hold |
933
| – | – | ﹤0.01% | 860 |
|
|
2022
Q4 | $77.4K | Sell |
933
-567
| -38% | -$47.1K | ﹤0.01% | 811 |
|
|
2022
Q3 | $90.9K | Hold |
1,500
| – | – | ﹤0.01% | 788 |
|
|
2022
Q2 | $110K | Hold |
1,500
| – | – | ﹤0.01% | 783 |
|
|
2022
Q1 | $102K | Hold |
1,500
| – | – | ﹤0.01% | 841 |
|
|
2021
Q4 | $138K | Buy |
+1,500
| New | +$138K | ﹤0.01% | 818 |
|